The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Current and future burden of breast cancer: Global statistics for 2020 and 2040
Open accessAbstract
BACKGROUND: Breast cancer is the most commonly diagnosed cancer worldwide, and its burden has been rising over the past decades. In this article, we examine and describe the global burden of breast cancer in 2020 and predictions for the year 2040. METHODS: Estimates of new female breast cancer cases and deaths in 2020 were abstracted from the GLOBOCAN database. Age-standardized incidence and mortality rates were calculated per 100,000 females by country, world region, and level of human development. Predicted cases and deaths were computed based on global demographic projections for the year 2040. RESULTS: Over 2.3 million new cases and 685,000 deaths from breast cancer occurred in 2020. Large geographic variation across countries and world regions exists, with incidence rates ranging from <40 per 100,000 females in some Asian and African countries, to over 80 per 100,000 in Australia/New Zealand, Northern America, and parts of Europe. Smaller geographical variation was observed for mortality; however, transitioning countries continue to carry a disproportionate share of breast cancer deaths relative to transitioned countries. By 2040, the burden from breast cancer is predicted to increase to over 3 million new cases and 1 million deaths every year because of population growth and ageing alone. CONCLUSION: Breast cancer is the most common cancer worldwide and continues to have a large impact on the global number of cancer deaths. Global efforts are needed to counteract its growing burden, especially in transitioning countries where incidence is rising rapidly, and mortality rates remain high.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Breast cancer has become the most commonly diagnosed cancer worldwide, surpassing lung cancer [1, 2].”
From Nanosensitizer-assisted sonodynamic therapy for breast cancer (2025) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“In terms of primary prevention, a reduction in excess body weight and alcohol consumption and increasing physical activity and breastfeeding may have an impact in reducing breast cancer incidence.58”
From Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. (2024) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Self-citationCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Self-citationEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Self-citationCancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 6,308
Self-citationAllemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Breast cancer statistics, 2019
Desantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Sauer, A. G., Jemal, A., & Siegel, R. L. (2019) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21583 · Cited by 3,222
Global cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
Breast-Cancer Screening — Viewpoint of the IARC Working Group
Secretan, B., Scoccianti, C., LOOMIS, D. P., Benbrahim‐Tallaa, L., Bouvard, V., Bianchini, F., & Straíf, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1504363 · Cited by 966
Flagged first, then by citations
1 of the 43 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 1,000
Harnessing the potency of scorpion venom-derived proteins: applications in cancer therapy
El-Qassas, J., El-Atti, M. A., & El‐Badri, N. (2024) · Bioresources and Bioprocessing · doi:10.1186/s40643-024-00805-0 · Cited by 25
Zahwe, M., Bendahhou, K., Eser, S., Mukherji, D., Fouad, H. M., Fadhil, I., Soerjomataram, I., & Znaor, A. (2025) · International Journal of Cancer · doi:10.1002/ijc.35325 · Cited by 24
Self-citationMantooth, S. M., Green, J. M., Green, W. D., Nguyen, K. G., Mantooth, K. A., Meritet, D., Milner, J. J., & Zaharoff, D. A. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113761 · Cited by 24
Epidemiology of Breast Cancer in Sub-Saharan Africa
Adeoye, P. A. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109361 · Cited by 24
The association between night shift work and breast cancer risk in the Finnish twins cohort
Schernhammer, E. S., Bogl, L. H., Hublin, C., Strohmaier, S., Żebrowska, M., Erber, A. C., Haghayegh, S., Papantoniou, K., Ollikainen, M., & Kaprio, J. A. (2023) · European Journal of Epidemiology · doi:10.1007/s10654-023-00983-9 · Cited by 24
Zhu, M., Sun, Y., Bai, H., Wang, Y., Yang, B., Wang, Q., & Kuang, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1159985 · Cited by 24
Zou, S., Yang, H.-Y., Ouyang, M., Cheng, Q., Shi, X., & Sun, M. (2023) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-023-00702-w · Cited by 24
Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells
Esquea, E. M., Ciraku, L., Young, R. G., Merzy, J., Talarico, A. N., Ahmed, N. N., Karuppiah, M., Ramesh, A., Chatoff, A. G., Crispim, C. V. D. S., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1394685 · Cited by 24
Kan, L. L., Chan, B. C.-L., Leung, P., & Wong, C. K. (2023) · Molecules · doi:10.3390/molecules28155804 · Cited by 24
Collagen-Binding Nanoparticles for Paclitaxel Encapsulation and Breast Cancer Treatment
Passos, J. S., Lopes, L. B., & Panitch, A. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01332 · Cited by 23
Latronico, T., Petraglia, T., Sileo, C., Bilancia, D., Rossano, R., & Liuzzi, G. M. (2024) · Molecules · doi:10.3390/molecules29081718 · Cited by 26
Jang, M. K., Park, S., Raszewski, R., Park, C. G., Doorenbos, A. Z., & Kim, S. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08532-0 · Cited by 25
Farouk, A. H., Aref, A., Fathy, B. A., & Abdallah, A. N. (2024) · Scientific Reports · doi:10.1038/s41598-024-59736-7 · Cited by 23
Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer
Ferro, C., Matos, A. I., Serpico, L., Fontana, F., Chiaro, J., D’Amico, C., Correia, A., Koivula, R., Kemell, M., Gaspar, M. M., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401523 · Cited by 23
Soman, S., Kulkarni, S., John, J., Vineeth, P. S., Ahmad, S. F., George, S. D., Nandakumar, K., & Mutalik, S. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124665 · Cited by 23
Targeting secretory autophagy in solid cancers: mechanisms, immune regulation and clinical insights
Li, X., & Zhao, H. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00603-0 · Cited by 25
Dumas, É., Jochum, F., Coussy, F., Hamy, A., Majdling, A., Houzard, S., Bihan-Benjamin, C. L., Reyal, F., Gougis, P., & Stensrud, M. J. (2025) · Journal of Clinical Oncology · doi:10.1200/jco.24.01131 · Cited by 24
New Insights in the Diagnostic Potential of Sex Hormone-Binding Globulin (SHBG)—Clinical Approach
Szybiak, W., Cyna, W., & Łącka, K. (2025) · Biomedicines · doi:10.3390/biomedicines13051207 · Cited by 23
Hayes, S. C., Dunn, M. R., Plinsinga, M. L., Reul-Hirche, H. M., Ren, Y., Laakso, E., & Troester, M. A. (2022) · Cancers · doi:10.3390/cancers14235998 · Cited by 23
CanDiag: Fog Empowered Transfer Deep Learning Based Approach for Cancer Diagnosis
Pati, A., Parhi, M., Pattanayak, B. K., Sahu, B., & Khasim, S. (2023) · Designs · doi:10.3390/designs7030057 · Cited by 23
Impact of Nanomedicine in Women's Metastatic Breast Cancer
Ashkarran, A. A., Lin, Z., Rana, J., Bumpers, H. L., Sempere, L. F., & Mahmoudi, M. (2023) · Small · doi:10.1002/smll.202301385 · Cited by 23
Lafi, Z. M., Alshaer, W., Gharaibeh, L. F., Alqudah, D. A., AlQuaissi, B., Bashaireh, B., & Ibrahim, A. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291981 · Cited by 23
Exploring the therapeutic potential of quercetin in cancer treatment: Targeting long non-coding RNAs
Sheikhnia, F., Fazilat, A., Rashidi, V., Azizzadeh, B., Mohammadi, M., Maghsoudi, H., & Majidinia, M. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155374 · Cited by 25
Burden of female breast and five gynecological cancers in China and worldwide
Tan, N., Wu, Y., Li, B., & Chen, W. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003293 · Cited by 23
Triglyceride-glucose index is a risk factor for breast cancer in China: a cross-sectional study
Zhang, J., Yin, B., Xi, Y., & Bai, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02008-0 · Cited by 22
AI-based hierarchical approach for optimizing breast cancer detection using MammoWave device
Taghipour‐Gorjikolaie, M., Ghavami, N., Papini, L., Badia, M., Fracassini, A., Bigotti, A., Palomba, G., Sánchez-Bayuela, D. Á., Castellano, C. R., Loretoni, R., et al. (2024) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.107143 · Cited by 22
Simancas‐Racines, D., Román-Galeano, N. M., Vásquez, J. P., Gavilanes, D. J., Vijayan, R., & Reytor-González, C. (2025) · Biomedicines · doi:10.3390/biomedicines13123073 · Cited by 31
Elmakaty, I., Abdo, R., Elsabagh, A. A., Elsayed, A., & Malki, M. I. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02941-7 · Cited by 22
Askar, M. A., El-Sayyad, G. S., Guida, M. S., Khalifa, E., SHABANA, E. S., & Abdelrahman, I. Y. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-03986-x · Cited by 22
Selected Flavonols in Breast and Gynecological Cancer: A Systematic Review
Wendlocha, D., Krzykawski, K., Mielczarek‐Palacz, A., & Kubina, R. (2023) · Nutrients · doi:10.3390/nu15132938 · Cited by 22
Abraham, M., Lak, M. A., Gurz, D., Nolasco, F. O. M., Kondraju, P. K., & Iqbal, J. (2023) · Cureus · doi:10.7759/cureus.44081 · Cited by 32
Zeb, A., Gul, M., Nguyen, T., & Maeng, H. (2023) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-023-00632-z · Cited by 22
High sensitivity saliva-based biosensor in detection of breast cancer biomarkers: HER2 and CA15-3
Wan, H.-H., Zhu, H., Chiang, C.-C., Li, J.-S., Ren, F., Tsai, C.-T., Liao, Y., Neal, D. W., Esquivel‐Upshaw, J. F., & Pearton, S. J. (2024) · Journal of Vacuum Science & Technology B Nanotechnology and Microelectronics Materials Processing Measurement and Phenomena · doi:10.1116/6.0003370 · Cited by 22
Ng, D. W. L., So, S. C. Y., Fielding, R., Mehnert, A., Kwong, A., Suen, D. T. K., Wong, L., Fung, S., Chun, O. K., Fong, D., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1340920 · Cited by 22
Olayiwola, Y., & Gollahon, L. (2024) · Pharmaceuticals · doi:10.3390/ph17030361 · Cited by 22
Decoding pathology: the role of computational pathology in research and diagnostics
Hölscher, D. L., & Bülow, R. D. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03002-2 · Cited by 23
Madhu, G., Bonasi, A. M., Kautish, S., Almazyad, A. S., Mohamed, A. W., Werner, F. M., Hosseinzadeh, M., & Shokouhifar, M. (2024) · Cancers · doi:10.3390/cancers16223777 · Cited by 21
Wekalao, J. (2025) · Plasmonics · doi:10.1007/s11468-025-02905-9 · Cited by 21
Sarnaik, S., Ahmed, H., Hussain, N., Kundu, S., Sahu, B. D., & Alexander, A. (2025) · ACS Omega · doi:10.1021/acsomega.5c05302 · Cited by 21
Hormonal Contraceptive Formulations and Breast Cancer Risk in Adolescents and Premenopausal Women
Hadizadeh, F., Koteci, A., Karlsson, T., Ek, W. E., & Johansson, Å. (2025) · JAMA Oncology · doi:10.1001/jamaoncol.2025.4480 · Cited by 21
Režuchová, I., Bartošová, M., Belvončíková, P., Takáčová, M., Zaťovičová, M., Jelenska, L., Csáderová, L., Mečiarová, I., & Pohlodek, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054325 · Cited by 22
Mauro, C., Capone, V., Cocchia, R., Cademartiri, F., Riccardi, F., Arcopinto, M., Alshahid, M., Anwar, K., Carafa, M., Carbone, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062121 · Cited by 21
Casal-Guisande, M., Álvarez-Pazó, A., Cerqueiro-Pequeño, J., Bouza-Rodríguez, J.-B., Lourido, G. P., & Comesaña-Campos, A. (2023) · Cancers · doi:10.3390/cancers15061711 · Cited by 21
Mohanty, S. K., Wadasadawala, T., Sen, S., & Khan, P. K. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02275-6 · Cited by 21
Non-Surgical Definitive Treatment for Operable Breast Cancer: Current Status and Future Prospects
Shibamoto, Y., & Takano, S. (2023) · Cancers · doi:10.3390/cancers15061864 · Cited by 21
Montoro, C. I., Alcaraz, M. D. C., & Galvez-Sánchez, C. M. (2023) · Behavioral Sciences · doi:10.3390/bs13050377 · Cited by 42
Zhang, L., Zhao, Y., Yang, J., Zhu, Y., Li, T., Liu, X., Zhang, P., Cheng, J., Sun, S., Wei, C., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1158087 · Cited by 21
Cadherin‐11 increases tumor cell proliferation and metastatic potential via Wnt pathway activation
Liu, Y., Lei, P., Samuel, R. Z., Kashyap, A. M., Groth, T., Bshara, W., Neelamegham, S., & Andreadis, S. T. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13507 · Cited by 21
Brown, R. B., Bigelow, P., Dubin, J. A., & Mielke, J. G. (2023) · Nutrients · doi:10.3390/nu15173735 · Cited by 21
Li, J., He, D., Bi, Y., & Liu, S. (2023) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s432750 · Cited by 21
Fernandes, N. B., Velagacherla, V., Spandana, K. J., Bhagya, N., Mehta, C. H., Gadag, S., Jayalakshmi, N. S., & Nayak, U. Y. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123686 · Cited by 21
Bloise, N., Giannaccari, M., Guagliano, G., Peluso, E., Restivo, E., Strada, S., Volpini, C., Petrini, P., & Visai, L. (2024) · Cells · doi:10.3390/cells13121054 · Cited by 24
Pati, A., Panigrahi, A., Parhi, M., Giri, J. P., Qin, H. H., Mallik, S., Pattanayak, S. R., & Agrawal, U. K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304768 · Cited by 21
Dr. Jekyll or Mr. Hyde: The multifaceted roles of miR-145-5p in human health and disease
Rahman, M. S., Ghorai, S., Panda, K., Santiago, M. J., Aggarwal, S., Wang, T., Rahman, I., Chinnapaiyan, S., & Unwalla, H. J. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.11.001 · Cited by 21
Application of VGG16 Transfer Learning for Breast Cancer Detection
Fatima, T., & Soliman, H. (2025) · Information · doi:10.3390/info16030227 · Cited by 25
Breast Ultrasound Image Detection Based on Dual-Branch Faster R-CNN
Liu, C., Yang, B., Zhang, L., Liu, C., & Zheng, W. (2025) · Electronics · doi:10.3390/electronics14214247 · Cited by 23
Idrees, B. S., Teng, G., Israr, A., Zaib, H., Jamil, Y., Bilal, M., Bashir, S., Khan, M. N., & Wang, Q. (2023) · Biomedical Optics Express · doi:10.1364/boe.489513 · Cited by 20
Recent advances in novel miRNA mediated approaches for targeting breast cancer
Ahmadi, S. M., Amirkhanloo, S., Robati, R. Y., Ebrahimi, H., Pirhayati, F. H., Almalki, W. H., Ebrahimnejad, P., & Kesharwani, P. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2240979 · Cited by 20
3D-based strain analysis and cardiotoxicity detection in cancer patients received chemotherapy
Azzam, M., Wasef, M., Khalaf, H. A. E., & Al‐Habbaa, A. (2023) · BMC Cancer · doi:10.1186/s12885-023-11261-y · Cited by 20
Rajana, N., Chary, P. S., Pooja, Y. S., Bhavana, V., Singh, H., Guru, S. K., Singh, S. B., & Mehra, N. K. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01462-0 · Cited by 20
Mohamed, S. Y., Elshoky, H. A., El‐Sayed, N. M., Fahmy, H. M., & Ali, M. A. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128597 · Cited by 23
Impact of heavy metals on breast cancer (Review)
Ali, A., Nazar, M., Mustafa, R. M., Hussein, S. H., Qurbani, K., & Ahmed, S. K. (2023) · World Academy of Sciences Journal · doi:10.3892/wasj.2023.219 · Cited by 21
Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy
Peres, C., Matos, A. I., Carreira, B., Moura, L. I. F., Kleiner, R., Vaskovich‐Koubi, D., Reshef, K., Dulberg, S., Verdial, M., Conniot, J., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202401749 · Cited by 20
Real-world clinical evaluation of natural and induced vasomotor symptoms in the USA and Europe
Kingsberg, S. A., Banks, V., Caetano, C., Janssenswillen, C., Möeller, C., Schoof, N., Lee, L., Scott, M., & Nappi, R. E. (2024) · Climacteric · doi:10.1080/13697137.2024.2340472 · Cited by 20
Fu, W., Liu, L., & Tong, S. (2024) · Thoracic Cancer · doi:10.1111/1759-7714.15321 · Cited by 20
Burciu, O. M., Sas, I., Popoiu, T.-A., Merce, A.-G., Moleriu, L. C., & Cobec, I. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158506 · Cited by 20
Rai, H. M., Dashkevych, S., & Yoo, J. (2024) · Mathematics · doi:10.3390/math12182808 · Cited by 20
Zhou, M., Li, H., Zhao, J., Zhang, Q., Han, Z., Han, Z., Zhu, L., Wang, H. Z., & Li, Z. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13316 · Cited by 19
Janni, W., Friedl, T. W. P., Yab, T. C., Bidard, F., Cristofanilli, M., Hayes, D. F., Ignatiadis, M., Regan, M. M., Alix‐Panabières, C., Barlow, W. E., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-3108 · Cited by 22
Expression profiles of FABP4 and FABP5 in breast cancer: clinical implications and perspectives
Jiang, X., Xiong, Y., Yu, J., Avellino, A., Liu, S., Han, X., Wang, Z., Shilyansky, J. S., Curry, M. A., Hao, J., et al. (2025) · Discover Oncology · doi:10.1007/s12672-025-02117-x · Cited by 19
Non-coding RNAs, a double-edged sword in breast cancer prognosis
Solaimani, M., Hosseinzadeh, S., & Abasi, M. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03679-0 · Cited by 19
Marinas-Sanz, R., Iguacel, I., Maqueda, J., Mínguez, L., Alquézar, P., Andrés, R., Pérez, E., Sousa, R., Moreno-Atahonero, E., Solé, D., et al. (2023) · Cancers · doi:10.3390/cancers15030874 · Cited by 19
Paclitaxel-lipid prodrug liposomes for improved drug delivery and breast carcinoma therapy
Wu, X. Y., Chen, X., Wang, X., Chen, X., Chen, J., & Wu, W. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.108756 · Cited by 19
Advances in the protein‑encoding functions of circular RNAs associated with cancer (Review)
Yuan, W., Zhang, X., & Cong, H. (2023) · Oncology Reports · doi:10.3892/or.2023.8597 · Cited by 19
Exploring the human microbiome – A step forward for precision medicine in breast cancer
Jotshi, A., Sukla, K. K., Haque, M. M., Bose, C., Varma, B., Koppiker, C. B., Joshi, S., & Mishra, R. (2023) · Cancer Reports · doi:10.1002/cnr2.1877 · Cited by 20
Dual targeting multiwalled carbon nanotubes for improved neratinib delivery in breast cancer
Lila, A. S. A., Bhattacharya, R., Moin, A., Hagbani, T. A., Abdallah, M. H., Rizvi, S. M. D., Khafagy, E., Hussain, T., & Gangadharappa, H. V. (2023) · RSC Advances · doi:10.1039/d3ra04732f · Cited by 19
Muñoz-Alcaraz, M. N., Jiménez-Vílchez, A. J., de Torres, L. Á. P., Serrano-Merino, J., García‐Bustillo, Á., Pardo-Hernández, R., Gonzalez-Bernal, J. J., & González‐Santos, J. (2023) · Healthcare · doi:10.3390/healthcare11182568 · Cited by 19
Guo, Q., Lu, Y., Liu, W., Lan, G., & Lan, T. (2024) · BMC Public Health · doi:10.1186/s12889-023-17405-w · Cited by 18
Ketogenic diet as a treatment and prevention strategy for cancer: A therapeutic alternative
Neha, N., & Chaudhary, R. (2024) · Nutrition · doi:10.1016/j.nut.2024.112427 · Cited by 20
Sun, M., Zhao, X., Cao, X., Li, X., Xu, J., Meng, X., Lu, H., & Zhao, X. (2024) · Talanta · doi:10.1016/j.talanta.2024.125991 · Cited by 19
Peng, L., Ren, M., Huang, L., & Chen, M. (2024) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-024-00619-w · Cited by 19
Chota, A., Abrahamse, H., & George, B. P. A. (2024) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2024.104252 · Cited by 22
Gupta, A., Yadav, S. K., Durai, C. A. D., Kuamr, V., Alsharif, M. H., Uthansakul, P., & Uthansakul, M. (2024) · Results in Engineering · doi:10.1016/j.rineng.2024.103044 · Cited by 19
Barathan, M., Ng, S. L., Lokanathan, Y., Ng, M. H., & Law, J. X. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050654 · Cited by 20
Clinical Pharmacist-Led Interventions for Improving Breast Cancer Management—A Scoping Review
Staynova, R. A., Gavazova, E., & Kafalova, D. (2024) · Current Oncology · doi:10.3390/curroncol31080312 · Cited by 18
Ying, H., Kong, W., & Xu, X. (2025) · OncoTargets and Therapy · doi:10.2147/ott.s486300 · Cited by 18
Dual‐View Deep Learning Model for Accurate Breast Cancer Detection in Mammograms
Shah, D., Khan, M. A. U., Abrar, M. Y. B. T., & Tahir, M. (2025) · International Journal of Intelligent Systems · doi:10.1155/int/7638868 · Cited by 18
Wawruszak, A., Łuszczki, J. J., Bartuzi, D., Kałafut, J., Okoń, E., Czerwonka, A., & Stepulak, A. (2025) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2025.2458554 · Cited by 18
Reytor-González, C., Simancas‐Racines, D., Román-Galeano, N. M., Campuzano-Donoso, M., Am, C., Zambrano-Villacres, R., Teresa, M., Coppola, L., Marchetti, M., Galasso, M., et al. (2025) · Food and Agricultural Immunology · doi:10.1080/09540105.2025.2521270 · Cited by 21
Enhanced Nanoprecipitation Method for the Production of PLGA Nanoparticles for Oncology Applications
Ghaly, H. S. A., Seyedasli, N., & Varamini, P. (2025) · The AAPS Journal · doi:10.1208/s12248-025-01096-9 · Cited by 21
Role of monocarboxylate transporters in cancer immunology and their therapeutic potential
Faghihkhorasani, F., Moosavi, M., Abdulwahid, A. R. R., Kavei, M., Karimi, S., Karimi, M. S., Vezvaei, P., Varkiani, M. M., Aref, A. R., & Ebrahimi, N. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70110 · Cited by 24
Vaijayanthimala, J., Vaishnavi, K., Kumar, U. A., & Dhivya, R. K. (2025) · Sensors International · doi:10.1016/j.sintl.2025.100350 · Cited by 18
Lactylation in cancer: molecular mechanisms and advances in clinical study
Li, J., Miao, C., Guo, H., Lin, M., Chen, R., Peng, J., Wang, J., Tang, C., & Chen, Z. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02573-1 · Cited by 21
Song, B., Nie, L., Bozorov, K. A., Niu, C., Kuryazov, R., Aisa, H. A., & Zhao, J. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202201059 · Cited by 18
Zaib, T., Cheng, K., Liu, T., Mei, R., Liu, Q., Zhou, X., He, L., Rashid, H., Xie, Q., Khan, H., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032152 · Cited by 18
Girich, E. V., Trinh, P. T. H., Nesterenko, L. E., Popov, R. S., Kim, N. Y., Rasin, A. B., Menchinskaya, E. S., Kuzmich, A. S., Chingizova, E. A., Минин, А. С., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098150 · Cited by 18
Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis
Wu, N., Sun, H., Sun, Q., Zhang, F., Ma, L., Hu, Y., & Cong, X. (2023) · BMC Cancer · doi:10.1186/s12885-023-10891-6 · Cited by 18
WWFedCBMIR: World-Wide Federated Content-Based Medical Image Retrieval
Tabatabaei, Z., Wang, Y., Colomer, A., Moll, J. O., Zhao, Z., & Naranjo, V. (2023) · Bioengineering · doi:10.3390/bioengineering10101144 · Cited by 18
Deep learning to predict breast cancer sentinel lymph node status on INSEMA histological images
Marmé, F., Krieghoff‐Henning, E., Gerber, B., Schmitt, M., Zahm, D.-M., Bauerschlag, D., Forstbauer, H., Hildebrandt, G., Ataseven, B., Brodkorb, T., et al. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.113390 · Cited by 18
Shao, H., Zhao, M., Guan, A., Shao, T., Zhou, D., Yu, G., & Tang, W. (2024) · BMC Medicine · doi:10.1186/s12916-023-03238-2 · Cited by 21
Metadata
- Authors
- Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., Vignat, J., Gralow, J. R., Cardoso, F., Siesling, S., & Soerjomataram, I.
- Affiliations
- Centre international de recherche sur le cancer (FR)
- American Society of Clinical Oncology (US)
- Netherlands Comprehensive Cancer Organisation (NL)
- Corresponding author
- Morgan, Eileen
- ORCID
- Venue
- The Breast
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 66
- Pages
- 15-23
- ISSN
- 0960-9776 (ISSN-L)
- PMC
- PMC9465273
- OpenAlex
- W4294189863
- Cited by
- 3,411
- References
- 43
- Citations by year
- 2026: 694 · 2025: 1176 · 2024: 997 · 2023: 516 · 2022: 23
- FWCI
- 284.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- The Breast (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- University of Twente Research Information (publishedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Twente Research Information (submittedVersion, cc-by-nc-nd)
- Funders
- Susan G. Komen (CCR19608129)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Keywords
- breast cancer, global burden of disease, incidence, mortality, age-standardized rates, population projections, 2040 projections, regional variation, human development, cancer epidemiology
- MeSH terms
- Australia, Breast Neoplasms, Europe, Female, Forecasting, Humans, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review